Show Summary Details
- Title Pages
- <b>ISSUES IN BIOMEDICAL ETHICS</b>
- Dedication
- <b>Acknowledgements</b>
- <i>Introduction</i>
- 1 <i>From 1966 to 2005: Balancing Protection and Access in Pediatric Research</i>
- 2 <b><i>Access versus Protection: Minority Representation in Pediatric Research</i></b>
- 3 <b><i>Overview of the Common Rule and Subpart D</i></b>
- 4 <b><i>Should We Provide Healthy Children with Greater Protection in Medical Research?</i></b>
- 5 <b><i>Informed Consent in Pediatric Research</i></b>
- 6 Phase I Research and the Meaning of ‘Prospect of Direct Benefit’
- 7 <b><i>Human Subject Protections in Pediatric Research</i></b>
- 8 <b><i>Payment in Pediatric Research</i></b>
- <b>9</b> <b><i>Research in Schools</i></b>
- 10 <b><i>Minimizing Risks: Diabetes Research in Newborns</i></b>
- 11 <b><i>Diabetes Prediction and Prevention Research in Childhood</i></b>
- 12 <b><i>Lead Abatement Research</i></b>
- 13 <i>Clinical Asthma Trials</i>
- 14 <b><i>Research not Otherwise Approvable: A Look at One 407 Protocol</i></b>
- 15 <b><i>Evolution of the 407 Process</i></b>
- <b><i>Epilogue</i></b>
- Index
(p.ii) ISSUES IN BIOMEDICAL ETHICS
(p.ii) ISSUES IN BIOMEDICAL ETHICS
- Source:
- Children in Medical Research
- Publisher:
- Oxford University Press
Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .
- Title Pages
- <b>ISSUES IN BIOMEDICAL ETHICS</b>
- Dedication
- <b>Acknowledgements</b>
- <i>Introduction</i>
- 1 <i>From 1966 to 2005: Balancing Protection and Access in Pediatric Research</i>
- 2 <b><i>Access versus Protection: Minority Representation in Pediatric Research</i></b>
- 3 <b><i>Overview of the Common Rule and Subpart D</i></b>
- 4 <b><i>Should We Provide Healthy Children with Greater Protection in Medical Research?</i></b>
- 5 <b><i>Informed Consent in Pediatric Research</i></b>
- 6 Phase I Research and the Meaning of ‘Prospect of Direct Benefit’
- 7 <b><i>Human Subject Protections in Pediatric Research</i></b>
- 8 <b><i>Payment in Pediatric Research</i></b>
- <b>9</b> <b><i>Research in Schools</i></b>
- 10 <b><i>Minimizing Risks: Diabetes Research in Newborns</i></b>
- 11 <b><i>Diabetes Prediction and Prevention Research in Childhood</i></b>
- 12 <b><i>Lead Abatement Research</i></b>
- 13 <i>Clinical Asthma Trials</i>
- 14 <b><i>Research not Otherwise Approvable: A Look at One 407 Protocol</i></b>
- 15 <b><i>Evolution of the 407 Process</i></b>
- <b><i>Epilogue</i></b>
- Index
